Tag: pfizer

  • PROFIT$ SOAR FOR PFIZER!

    PROFIT$ SOAR FOR PFIZER!

    PFIZER EXPECTS $54 BILLION IN 2022 SALES ON COVID VACCINE AND TREATMENT PILL →

    • Pfizer expects to sell $32 billion of its Covid-19 shots and $22 billion of its antiviral coronavirus treatment pill Paxlovid
    • But the drugmaker posted mixed fourth-quarter results, beating on earnings but missing on revenue.
    • Pfizer forecasts $98 billion to $102 billion in sales for 2022, and adjusted earnings per share of $6.35 to $6.55.
    • On an unadjusted basis, fourth-quarter profit soared more than fourfold to $3.39 billion.

    ….and profits are theirs..

    Pfizer Inc said on Tuesday it expects 2022 sales of its COVID-19 vaccine and antiviral pill to top $54 billion, but that fell short of lofty Wall Street estimates and its shares were off about 3%.

    Still, Chief Executive Albert Bourla said final sales for its oral COVID-19 antiviral, Paxlovid, could be “way bigger” than what Pfizer has forecast since its current outlook only included contracts that have been or are close to being signed.

    Pfizer currently expects $22 billion in 2022 sales of the treatment, compared with Wall Street estimates of $22.88 billion.

  • Pfizer set to submit to FDA: Covid vaccine ‘safe’ in kids

    Pfizer set to submit to FDA: Covid vaccine ‘safe’ in kids

    Pfizer and BioNTech’s Covid-19 vaccine is safe and generates a “robust” immune response in a clinical trial of kids ages 5 to 11, the drugmakers announced Monday.

    The companies tested a two-dose regimen of 10 micrograms — about a third the dosage used for teens and adults — administered three weeks apart. They said the shots were well tolerated and produced an immune response and side effects comparable to those seen in a study of people ages 16 to 25

  • IT’S DO OR DIE! PFIZER GETS FULL APPROVAL!

    IT’S DO OR DIE! PFIZER GETS FULL APPROVAL!

    PFIZER GETS APPROVAL! Up until now, the mRNA vaccine, which will be marketed as Comirnaty, was on the U.S. market under an Emergency Use Authorization that was granted by the FDA in December. Since then, more than 204 million of the Pfizer shots have been administered, according to data compiled by the Centers for Disease Control and Prevention.

    MORE..

    “The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty, for the prevention of COVID-19 disease in individuals 16 years of age and older,” the FDA said in its announcement on Monday.

    The Pfizer/BioNTech vaccine has been authorized for emergency use in the United States since mid-December for people age 16 and older. In May, the authorization was extended to those 12 and older.

    “The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals,” according to the FDA.